Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ckd 501
2. Ckd-501
3. Ckd501
4. Lobeglitazone
1. Ckd-501
2. Chembl3780740
3. 763108-62-9 (sulfate)
4. 95c712e83p
5. 763108-62-9
6. 5-(4-(2-((6-(4-methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione Sulfate
7. Unii-95c712e83p
8. Ckd 501
9. Bdbm50152829
10. Lobeglitazone Sulfate [who-dd]
11. Sb16870
12. Q27271778
13. (+/-)-2,4-thiazolidinedione, 5-((4-(2-((6-(4-methoxyphenoxy)-4-pyrimidinyl)methylamino)ethoxy)phenyl)methyl)-, Sulfate (1:1)
14. 2,4-thiazolidinedione, 5-((4-(2-((6-(4-methoxyphenoxy)-4- Pyrimidinyl)methylamino)ethoxy)phenyl)methyl)-, Sulfate (1:1)
15. 2,4-thiazolidinedione, 5-((4-(2-((6-(4-methoxyphenoxy)-4-pyrimidinyl)methylamino)ethoxy)phenyl)methyl)-, Sulfate (1:1)
16. 5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;sulfuric Acid
| Molecular Weight | 578.6 g/mol |
|---|---|
| Molecular Formula | C24H26N4O9S2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 10 |
| Exact Mass | 578.11412077 g/mol |
| Monoisotopic Mass | 578.11412077 g/mol |
| Topological Polar Surface Area | 211 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 751 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
A Lobeglitazone sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lobeglitazone sulfate, including repackagers and relabelers. The FDA regulates Lobeglitazone sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lobeglitazone sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lobeglitazone sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lobeglitazone sulfate supplier is an individual or a company that provides Lobeglitazone sulfate active pharmaceutical ingredient (API) or Lobeglitazone sulfate finished formulations upon request. The Lobeglitazone sulfate suppliers may include Lobeglitazone sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Lobeglitazone sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lobeglitazone sulfate Drug Master File in Korea (Lobeglitazone sulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lobeglitazone sulfate. The MFDS reviews the Lobeglitazone sulfate KDMF as part of the drug registration process and uses the information provided in the Lobeglitazone sulfate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lobeglitazone sulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lobeglitazone sulfate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lobeglitazone sulfate suppliers with KDMF on PharmaCompass.
Lobeglitazone sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lobeglitazone sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lobeglitazone sulfate GMP manufacturer or Lobeglitazone sulfate GMP API supplier for your needs.
A Lobeglitazone sulfate CoA (Certificate of Analysis) is a formal document that attests to Lobeglitazone sulfate's compliance with Lobeglitazone sulfate specifications and serves as a tool for batch-level quality control.
Lobeglitazone sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Lobeglitazone sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lobeglitazone sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lobeglitazone sulfate EP), Lobeglitazone sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lobeglitazone sulfate USP).
LOOKING FOR A SUPPLIER?
